Health Care & Life Sciences » Biotechnology | Anterogen Co. Ltd.

Anterogen Co. Ltd.

Anterogen Co. Ltd.
Stock Exchange Korea Exchange
EPS
KRW147
Market Cap
KRW753.21 B
Shares Outstanding
7.95 M
Public Float
4.78 M

Profile

Address
Unit 405, Namsung Plaza
Seoul SL 08589
Korea, Republic Of
Employees -
Website http://www.anterogen.com
Updated 09/14/2018
Anterogen Co., Ltd. develops stem cell therapy treatments. Its products include Cupistem and Remodullin injection, Queencell and stem cell conditioned media. In addition, It also offers stem cell banking and analysis services.

Financials

View All

Bang-Hee Han
Senior Managing Director & Head-Clinic
Mi-Hyung Kim
Senior Managing Director & Head-Research Institute